

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of hypersensitivity (GO:0002883) | 6.15566961 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.54759378 |
| 3 | central nervous system myelination (GO:0022010) | 5.54759378 |
| 4 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 5.25672643 |
| 5 | positive regulation of mast cell degranulation (GO:0043306) | 5.25672643 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.11969202 |
| 7 | positive regulation of cellular amide metabolic process (GO:0034250) | 5.08915096 |
| 8 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.86052225 |
| 9 | positive regulation of leukocyte degranulation (GO:0043302) | 4.45454506 |
| 10 | positive regulation of mast cell activation (GO:0033005) | 4.41677378 |
| 11 | immunoglobulin mediated immune response (GO:0016064) | 4.38748378 |
| 12 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 4.32962205 |
| 13 | necroptotic process (GO:0070266) | 4.32540419 |
| 14 | * positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.19894468 |
| 15 | L-amino acid import (GO:0043092) | 4.08288498 |
| 16 | fatty acid elongation (GO:0030497) | 4.06131304 |
| 17 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91167337 |
| 18 | response to peptidoglycan (GO:0032494) | 3.87857111 |
| 19 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.85309649 |
| 20 | C4-dicarboxylate transport (GO:0015740) | 3.82755758 |
| 21 | * regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.72088545 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.70318752 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64980697 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 3.64980697 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64980697 |
| 26 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64980697 |
| 27 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64980697 |
| 28 | modulation by symbiont of host immune response (GO:0052553) | 3.64980697 |
| 29 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.63526843 |
| 30 | B cell mediated immunity (GO:0019724) | 3.62323414 |
| 31 | amino acid import (GO:0043090) | 3.57125289 |
| 32 | microglial cell activation (GO:0001774) | 3.56745225 |
| 33 | programmed necrotic cell death (GO:0097300) | 3.55818408 |
| 34 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.48294823 |
| 35 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.43724292 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.37342746 |
| 37 | cholesterol biosynthetic process (GO:0006695) | 3.37029997 |
| 38 | negative regulation of astrocyte differentiation (GO:0048712) | 3.34596688 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.32948891 |
| 40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.30557023 |
| 41 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.26132724 |
| 42 | very long-chain fatty acid metabolic process (GO:0000038) | 3.23671943 |
| 43 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.23057029 |
| 44 | regulation of chemokine biosynthetic process (GO:0045073) | 3.22190829 |
| 45 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.19927384 |
| 46 | necrotic cell death (GO:0070265) | 3.19181198 |
| 47 | keratinization (GO:0031424) | 3.16403323 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14513129 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.12679601 |
| 50 | purine ribonucleotide transport (GO:0015868) | 3.11415974 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 3.11070118 |
| 52 | regulation of mast cell activation (GO:0033003) | 3.10753202 |
| 53 | positive regulation of antigen processing and presentation (GO:0002579) | 3.08973007 |
| 54 | phospholipid efflux (GO:0033700) | 3.06141591 |
| 55 | regulation of vitamin metabolic process (GO:0030656) | 3.05756782 |
| 56 | cellular response to cholesterol (GO:0071397) | 3.04117041 |
| 57 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.02267506 |
| 58 | reverse cholesterol transport (GO:0043691) | 2.99984801 |
| 59 | mature B cell differentiation involved in immune response (GO:0002313) | 2.98379376 |
| 60 | sterol biosynthetic process (GO:0016126) | 2.97600939 |
| 61 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.97253627 |
| 62 | granulocyte activation (GO:0036230) | 2.95490070 |
| 63 | myeloid cell activation involved in immune response (GO:0002275) | 2.94384867 |
| 64 | L-serine transport (GO:0015825) | 2.92975421 |
| 65 | sphingosine metabolic process (GO:0006670) | 2.92682111 |
| 66 | purine nucleotide transport (GO:0015865) | 2.92151204 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90522016 |
| 68 | oligodendrocyte differentiation (GO:0048709) | 2.89869327 |
| 69 | serine transport (GO:0032329) | 2.88961439 |
| 70 | regulation of metalloenzyme activity (GO:0048552) | 2.88102485 |
| 71 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.87510615 |
| 72 | positive regulation of acute inflammatory response (GO:0002675) | 2.86520505 |
| 73 | neutrophil activation (GO:0042119) | 2.85449312 |
| 74 | regulation of podosome assembly (GO:0071801) | 2.85250516 |
| 75 | establishment of skin barrier (GO:0061436) | 2.84341525 |
| 76 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83797916 |
| 77 | cellular response to interferon-gamma (GO:0071346) | 2.83789193 |
| 78 | cellular anion homeostasis (GO:0030002) | 2.83678777 |
| 79 | detection of other organism (GO:0098543) | 2.83445521 |
| 80 | lipoxygenase pathway (GO:0019372) | 2.82581879 |
| 81 | regulation of cholesterol esterification (GO:0010872) | 2.80447220 |
| 82 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.79683353 |
| 83 | regulation of antigen processing and presentation (GO:0002577) | 2.77285448 |
| 84 | defense response to protozoan (GO:0042832) | 2.77225673 |
| 85 | cellular response to zinc ion (GO:0071294) | 2.76744407 |
| 86 | autophagic vacuole fusion (GO:0000046) | 2.76401757 |
| 87 | daunorubicin metabolic process (GO:0044597) | 2.75787665 |
| 88 | polyketide metabolic process (GO:0030638) | 2.75787665 |
| 89 | doxorubicin metabolic process (GO:0044598) | 2.75787665 |
| 90 | positive regulation of regulated secretory pathway (GO:1903307) | 2.75430482 |
| 91 | regulation of interferon-alpha production (GO:0032647) | 2.74460781 |
| 92 | regulation of heat generation (GO:0031650) | 2.73620632 |
| 93 | response to auditory stimulus (GO:0010996) | 2.73030031 |
| 94 | adenine nucleotide transport (GO:0051503) | 2.72355074 |
| 95 | response to host immune response (GO:0052572) | 2.71482487 |
| 96 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.71482487 |
| 97 | alpha-linolenic acid metabolic process (GO:0036109) | 2.71098429 |
| 98 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.71086836 |
| 99 | regulation of beta-amyloid formation (GO:1902003) | 2.70961532 |
| 100 | response to protozoan (GO:0001562) | 2.70681163 |
| 101 | linoleic acid metabolic process (GO:0043651) | 2.70513739 |
| 102 | response to interferon-gamma (GO:0034341) | 2.70310868 |
| 103 | eosinophil chemotaxis (GO:0048245) | 2.68844527 |
| 104 | positive regulation of prostaglandin secretion (GO:0032308) | 2.68166802 |
| 105 | diol metabolic process (GO:0034311) | 2.68123550 |
| 106 | ceramide catabolic process (GO:0046514) | 2.67893228 |
| 107 | L-serine metabolic process (GO:0006563) | 2.67135476 |
| 108 | regulation of monocyte chemotaxis (GO:0090025) | 2.66816674 |
| 109 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.65859057 |
| 110 | regulation of mononuclear cell migration (GO:0071675) | 2.65292923 |
| 111 | protein-lipid complex remodeling (GO:0034368) | 2.65160557 |
| 112 | macromolecular complex remodeling (GO:0034367) | 2.65160557 |
| 113 | plasma lipoprotein particle remodeling (GO:0034369) | 2.65160557 |
| 114 | * T-helper 1 type immune response (GO:0042088) | 2.64099512 |
| 115 | positive regulation of interleukin-10 production (GO:0032733) | 2.62624074 |
| 116 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.61423726 |
| 117 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.61111150 |
| 118 | positive regulation of B cell mediated immunity (GO:0002714) | 2.61111150 |
| 119 | sulfur amino acid catabolic process (GO:0000098) | 2.60634988 |
| 120 | glycosphingolipid catabolic process (GO:0046479) | 2.58933880 |
| 121 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57777802 |
| 122 | detection of bacterium (GO:0016045) | 2.57523233 |
| 123 | myelin maintenance (GO:0043217) | 2.57290813 |
| 124 | negative regulation of interleukin-17 production (GO:0032700) | 2.56154943 |
| 125 | cellular response to sterol (GO:0036315) | 2.55321870 |
| 126 | myelination (GO:0042552) | 2.54839262 |
| 127 | positive regulation of interferon-alpha production (GO:0032727) | 2.54541086 |
| 128 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.53726331 |
| 129 | leukotriene biosynthetic process (GO:0019370) | 2.52615104 |
| 130 | cyclooxygenase pathway (GO:0019371) | 2.51958488 |
| 131 | ensheathment of neurons (GO:0007272) | 2.51930864 |
| 132 | axon ensheathment (GO:0008366) | 2.51930864 |
| 133 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.51473806 |
| 134 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.51302864 |
| 135 | nucleotide transport (GO:0006862) | 2.51288946 |
| 136 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.50676837 |
| 137 | positive regulation of interferon-beta production (GO:0032728) | 2.50097336 |
| 138 | high-density lipoprotein particle remodeling (GO:0034375) | 2.49160556 |
| 139 | sphingomyelin metabolic process (GO:0006684) | 2.49065379 |
| 140 | positive regulation of type 2 immune response (GO:0002830) | 2.48716767 |
| 141 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.48470514 |
| 142 | positive regulation of defense response to virus by host (GO:0002230) | 2.48321534 |
| 143 | positive regulation of heat generation (GO:0031652) | 2.47197269 |
| 144 | sphingoid metabolic process (GO:0046519) | 2.46973278 |
| 145 | cellular response to cadmium ion (GO:0071276) | 2.46870599 |
| 146 | eosinophil migration (GO:0072677) | 2.46853024 |
| 147 | cellular response to exogenous dsRNA (GO:0071360) | 2.46288425 |
| 148 | intracellular pH reduction (GO:0051452) | 2.45889600 |
| 149 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.45341075 |
| 150 | regulation of prostaglandin secretion (GO:0032306) | 2.45156195 |
| 151 | regulation of cellular amide metabolic process (GO:0034248) | 2.44471236 |
| 152 | plasma lipoprotein particle organization (GO:0071827) | 2.44090198 |
| 153 | positive regulation of interleukin-6 production (GO:0032755) | 2.43249505 |
| 154 | response to host (GO:0075136) | 2.43207140 |
| 155 | response to host defenses (GO:0052200) | 2.43207140 |
| 156 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.43207140 |
| 157 | phagocytosis, engulfment (GO:0006911) | 2.43032132 |
| 158 | macrophage chemotaxis (GO:0048246) | 2.42315818 |
| 159 | regulation of water loss via skin (GO:0033561) | 2.41950316 |
| 160 | adhesion of symbiont to host cell (GO:0044650) | 2.38445255 |
| 161 | virion attachment to host cell (GO:0019062) | 2.38445255 |
| 162 | alanine transport (GO:0032328) | 2.37644975 |
| 163 | flavonoid metabolic process (GO:0009812) | 2.37096071 |
| 164 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.36804723 |
| 165 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.36445089 |
| 166 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.36123107 |
| 167 | cholesterol efflux (GO:0033344) | 2.35520737 |
| 168 | regulation of astrocyte differentiation (GO:0048710) | 2.35520717 |
| 169 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.35282293 |
| 170 | plasma lipoprotein particle assembly (GO:0034377) | 2.32011925 |
| 171 | cellular ketone body metabolic process (GO:0046950) | 2.31360730 |
| 172 | regulation of cholesterol metabolic process (GO:0090181) | 2.31265775 |
| 173 | macrophage activation involved in immune response (GO:0002281) | 2.30446961 |
| 174 | protein-lipid complex subunit organization (GO:0071825) | 2.30168935 |
| 175 | photoreceptor cell differentiation (GO:0046530) | 2.29741302 |
| 176 | eye photoreceptor cell differentiation (GO:0001754) | 2.29741302 |
| 177 | acidic amino acid transport (GO:0015800) | 2.29306565 |
| 178 | nucleotide transmembrane transport (GO:1901679) | 2.28883337 |
| 179 | neurotransmitter uptake (GO:0001504) | 2.27188169 |
| 180 | response to lipoprotein particle (GO:0055094) | 2.24682076 |
| 181 | positive regulation of fatty acid transport (GO:2000193) | 2.24443150 |
| 182 | negative regulation of sterol transport (GO:0032372) | 2.23340717 |
| 183 | negative regulation of cholesterol transport (GO:0032375) | 2.23340717 |
| 184 | cellular potassium ion homeostasis (GO:0030007) | 2.20907893 |
| 185 | thioester biosynthetic process (GO:0035384) | 2.19068815 |
| 186 | acyl-CoA biosynthetic process (GO:0071616) | 2.19068815 |
| 187 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.18774431 |
| 188 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.18568726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.51968448 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.19215489 |
| 3 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.02126256 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 2.99041538 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.92736915 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59195828 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.52332911 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.37194566 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.28652953 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.28646140 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.25038025 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.22674723 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18562495 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.13114383 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.07466881 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.07283683 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06395001 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.05353773 |
| 19 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.02297368 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.01744024 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.00731043 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.94167092 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93605229 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86688315 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.86244593 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.83187949 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.80034231 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78473556 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75527176 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74105742 |
| 31 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.73878340 |
| 32 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.73878340 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68457859 |
| 34 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67589757 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67421965 |
| 36 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.65777595 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.65031386 |
| 38 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.64439942 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59853484 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59460570 |
| 41 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58846433 |
| 42 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.54734725 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54551462 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.53326507 |
| 45 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53266073 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.52821946 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52392793 |
| 48 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.51408858 |
| 49 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50575779 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48624362 |
| 51 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.47506431 |
| 52 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.47266479 |
| 53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.46361593 |
| 54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.46361593 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46351154 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43951281 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43793691 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41176550 |
| 59 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39033173 |
| 60 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37499399 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37310718 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37282250 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35904722 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34324977 |
| 65 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33607899 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.32668558 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31999601 |
| 68 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.31979656 |
| 69 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.31013725 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29683864 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27999122 |
| 72 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.27774130 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.27666357 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26988581 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26490292 |
| 76 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25293468 |
| 77 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24929654 |
| 78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23582954 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22458252 |
| 80 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22382957 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21242659 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18385091 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17826993 |
| 84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17826993 |
| 85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.16649775 |
| 86 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16246588 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 1.15314072 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15156074 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14480300 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13784844 |
| 91 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13160288 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12573175 |
| 93 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12439582 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11893612 |
| 95 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10081704 |
| 96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09880461 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09583011 |
| 98 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07274747 |
| 99 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07257536 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06435260 |
| 101 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05443618 |
| 102 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05193202 |
| 103 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04982105 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02616983 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02557947 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02487579 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.02273222 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02256474 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02254807 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01730956 |
| 111 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01301258 |
| 112 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00740300 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99387852 |
| 114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98253031 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97459893 |
| 116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97388649 |
| 117 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.97132747 |
| 118 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96836638 |
| 119 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96182574 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95772445 |
| 121 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95514484 |
| 122 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93605705 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93362750 |
| 124 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93124564 |
| 125 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92936577 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92609449 |
| 127 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92327446 |
| 128 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92031244 |
| 129 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.91476837 |
| 130 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91469978 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91153408 |
| 132 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91104890 |
| 133 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.91099479 |
| 134 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.91002187 |
| 135 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89186274 |
| 136 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88861111 |
| 137 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88384595 |
| 138 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.87666335 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87046828 |
| 140 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86405409 |
| 141 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.86404605 |
| 142 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.86398142 |
| 143 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86090687 |
| 144 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.85805425 |
| 145 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85797688 |
| 146 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85699199 |
| 147 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85664824 |
| 148 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.85214873 |
| 149 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84819388 |
| 150 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84781688 |
| 151 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84506318 |
| 152 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84455084 |
| 153 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84303362 |
| 154 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83187198 |
| 155 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.83043029 |
| 156 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82923475 |
| 157 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.82734685 |
| 158 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82699126 |
| 159 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.82683202 |
| 160 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82556313 |
| 161 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.82239585 |
| 162 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82239312 |
| 163 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81736878 |
| 164 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.81345198 |
| 165 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81071554 |
| 166 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.80463784 |
| 167 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80328694 |
| 168 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.80187261 |
| 169 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79723722 |
| 170 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.76752650 |
| 171 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75981377 |
| 172 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.75626076 |
| 173 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75594985 |
| 174 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75540875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 3.95822555 |
| 2 | MP0003690_abnormal_glial_cell | 3.40648078 |
| 3 | MP0005360_urolithiasis | 3.02764919 |
| 4 | MP0003303_peritoneal_inflammation | 2.84694142 |
| 5 | MP0002254_reproductive_system_inflammat | 2.80683639 |
| 6 | MP0003436_decreased_susceptibility_to | 2.55503708 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.38287290 |
| 8 | MP0000920_abnormal_myelination | 2.34286171 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 2.31469295 |
| 10 | MP0003329_amyloid_beta_deposits | 2.28335351 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.26948822 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.25446673 |
| 13 | MP0003136_yellow_coat_color | 2.23521841 |
| 14 | MP0000566_synostosis | 2.09699311 |
| 15 | MP0003011_delayed_dark_adaptation | 2.02828295 |
| 16 | MP0001800_abnormal_humoral_immune | 2.00170218 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.99743042 |
| 18 | MP0009384_cardiac_valve_regurgitation | 1.93417025 |
| 19 | MP0000343_altered_response_to | 1.90566798 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.87133847 |
| 21 | MP0008875_abnormal_xenobiotic_pharmacok | 1.86394530 |
| 22 | MP0002234_abnormal_pharynx_morphology | 1.86271312 |
| 23 | MP0002723_abnormal_immune_serum | 1.85829305 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.84823132 |
| 25 | MP0005451_abnormal_body_composition | 1.83655210 |
| 26 | MP0000604_amyloidosis | 1.82915268 |
| 27 | MP0003453_abnormal_keratinocyte_physiol | 1.81590494 |
| 28 | MP0001853_heart_inflammation | 1.75926779 |
| 29 | MP0009764_decreased_sensitivity_to | 1.73228231 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.69003863 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.68048369 |
| 32 | * MP0003075_altered_response_to | 1.68027447 |
| 33 | MP0001486_abnormal_startle_reflex | 1.66848755 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.62906060 |
| 35 | MP0001819_abnormal_immune_cell | 1.62645212 |
| 36 | MP0002090_abnormal_vision | 1.62396043 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.60964097 |
| 38 | MP0000685_abnormal_immune_system | 1.59411584 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.58128016 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.56641876 |
| 41 | * MP0001873_stomach_inflammation | 1.56143057 |
| 42 | MP0003880_abnormal_central_pattern | 1.55356579 |
| 43 | MP0005171_absent_coat_pigmentation | 1.55235522 |
| 44 | MP0006082_CNS_inflammation | 1.54068706 |
| 45 | MP0009785_altered_susceptibility_to | 1.49951635 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.49539705 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.49539705 |
| 48 | MP0004885_abnormal_endolymph | 1.47364505 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.45444624 |
| 50 | MP0000858_altered_metastatic_potential | 1.40757939 |
| 51 | MP0002405_respiratory_system_inflammati | 1.40375169 |
| 52 | * MP0002419_abnormal_innate_immunity | 1.39341065 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.38716259 |
| 54 | MP0004858_abnormal_nervous_system | 1.37887165 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.37409402 |
| 56 | MP0001216_abnormal_epidermal_layer | 1.37133428 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.35718895 |
| 58 | * MP0003634_abnormal_glial_cell | 1.34627823 |
| 59 | MP0002796_impaired_skin_barrier | 1.33378310 |
| 60 | MP0005332_abnormal_amino_acid | 1.33017911 |
| 61 | MP0002148_abnormal_hypersensitivity_rea | 1.32903316 |
| 62 | MP0004510_myositis | 1.28828995 |
| 63 | MP0003252_abnormal_bile_duct | 1.27740153 |
| 64 | MP0010329_abnormal_lipoprotein_level | 1.26301709 |
| 65 | MP0009278_abnormal_bone_marrow | 1.26156502 |
| 66 | MP0001790_abnormal_immune_system | 1.25909564 |
| 67 | MP0005387_immune_system_phenotype | 1.25909564 |
| 68 | MP0001984_abnormal_olfaction | 1.24645782 |
| 69 | MP0003878_abnormal_ear_physiology | 1.24107493 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.24107493 |
| 71 | MP0005501_abnormal_skin_physiology | 1.23390380 |
| 72 | MP0003633_abnormal_nervous_system | 1.23387762 |
| 73 | MP0001501_abnormal_sleep_pattern | 1.22710734 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.22342751 |
| 75 | MP0003448_altered_tumor_morphology | 1.20564011 |
| 76 | MP0002118_abnormal_lipid_homeostasis | 1.18926362 |
| 77 | MP0005085_abnormal_gallbladder_physiolo | 1.18382700 |
| 78 | MP0005365_abnormal_bile_salt | 1.18295144 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.15733623 |
| 80 | MP0004947_skin_inflammation | 1.13987671 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.13200103 |
| 82 | MP0003763_abnormal_thymus_physiology | 1.12961325 |
| 83 | MP0004142_abnormal_muscle_tone | 1.12737136 |
| 84 | MP0008004_abnormal_stomach_pH | 1.11446186 |
| 85 | * MP0005025_abnormal_response_to | 1.10940213 |
| 86 | MP0004742_abnormal_vestibular_system | 1.10890392 |
| 87 | MP0005023_abnormal_wound_healing | 1.09453066 |
| 88 | * MP0000716_abnormal_immune_system | 1.08560093 |
| 89 | MP0001851_eye_inflammation | 1.08011791 |
| 90 | MP0001905_abnormal_dopamine_level | 1.07029051 |
| 91 | MP0009379_abnormal_foot_pigmentation | 1.06576915 |
| 92 | MP0002736_abnormal_nociception_after | 1.03891641 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03409572 |
| 94 | MP0002064_seizures | 1.02800236 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 1.01278290 |
| 96 | * MP0005166_decreased_susceptibility_to | 1.00705465 |
| 97 | MP0005670_abnormal_white_adipose | 1.00291301 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 1.00167987 |
| 99 | MP0002229_neurodegeneration | 0.99369703 |
| 100 | MP0001440_abnormal_grooming_behavior | 0.96366763 |
| 101 | MP0005464_abnormal_platelet_physiology | 0.96184352 |
| 102 | MP0003631_nervous_system_phenotype | 0.95669301 |
| 103 | MP0004883_abnormal_blood_vessel | 0.95054119 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 0.93780573 |
| 105 | MP0005165_increased_susceptibility_to | 0.93172216 |
| 106 | MP0000681_abnormal_thyroid_gland | 0.92814454 |
| 107 | MP0002132_abnormal_respiratory_system | 0.92718237 |
| 108 | * MP0000465_gastrointestinal_hemorrhage | 0.92096941 |
| 109 | MP0000249_abnormal_blood_vessel | 0.91657107 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.91610377 |
| 111 | MP0005671_abnormal_response_to | 0.91260845 |
| 112 | MP0002398_abnormal_bone_marrow | 0.90228175 |
| 113 | MP0000383_abnormal_hair_follicle | 0.90120163 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.89340528 |
| 115 | MP0009763_increased_sensitivity_to | 0.89149094 |
| 116 | MP0004019_abnormal_vitamin_homeostasis | 0.88832648 |
| 117 | MP0003172_abnormal_lysosome_physiology | 0.88528453 |
| 118 | MP0004130_abnormal_muscle_cell | 0.88264935 |
| 119 | MP0001764_abnormal_homeostasis | 0.87572579 |
| 120 | MP0003724_increased_susceptibility_to | 0.87367951 |
| 121 | MP0002272_abnormal_nervous_system | 0.86280644 |
| 122 | MP0000647_abnormal_sebaceous_gland | 0.86146077 |
| 123 | * MP0001664_abnormal_digestion | 0.86061935 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.85915804 |
| 125 | MP0002006_tumorigenesis | 0.84960571 |
| 126 | MP0005000_abnormal_immune_tolerance | 0.84403997 |
| 127 | MP0004808_abnormal_hematopoietic_stem | 0.84379512 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.84358359 |
| 129 | MP0002098_abnormal_vibrissa_morphology | 0.84301504 |
| 130 | * MP0002429_abnormal_blood_cell | 0.83838474 |
| 131 | * MP0001663_abnormal_digestive_system | 0.83372923 |
| 132 | * MP0008469_abnormal_protein_level | 0.83077458 |
| 133 | MP0003632_abnormal_nervous_system | 0.81655416 |
| 134 | MP0005310_abnormal_salivary_gland | 0.81301652 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.80470667 |
| 136 | MP0001529_abnormal_vocalization | 0.79244353 |
| 137 | MP0004043_abnormal_pH_regulation | 0.79174854 |
| 138 | MP0005164_abnormal_response_to | 0.79153618 |
| 139 | MP0001986_abnormal_taste_sensitivity | 0.78904183 |
| 140 | MP0009745_abnormal_behavioral_response | 0.78011341 |
| 141 | MP0004270_analgesia | 0.77381874 |
| 142 | * MP0002452_abnormal_antigen_presenting | 0.77364721 |
| 143 | MP0009697_abnormal_copulation | 0.76949315 |
| 144 | MP0005319_abnormal_enzyme/_coenzyme | 0.76740505 |
| 145 | MP0010678_abnormal_skin_adnexa | 0.76709104 |
| 146 | MP0003186_abnormal_redox_activity | 0.75775870 |
| 147 | MP0000689_abnormal_spleen_morphology | 0.75674014 |
| 148 | MP0000579_abnormal_nail_morphology | 0.75673536 |
| 149 | MP0002396_abnormal_hematopoietic_system | 0.74719120 |
| 150 | MP0005666_abnormal_adipose_tissue | 0.74686603 |
| 151 | MP0001191_abnormal_skin_condition | 0.73887333 |
| 152 | MP0003868_abnormal_feces_composition | 0.73818122 |
| 153 | MP0010155_abnormal_intestine_physiology | 0.73585435 |
| 154 | MP0005595_abnormal_vascular_smooth | 0.72979442 |
| 155 | MP0005410_abnormal_fertilization | 0.72260046 |
| 156 | MP0002877_abnormal_melanocyte_morpholog | 0.71863142 |
| 157 | MP0002822_catalepsy | 0.71852907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 7.10044218 |
| 2 | Neurofibrillary tangles (HP:0002185) | 5.48513269 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.97231498 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.97231498 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.97231498 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 4.87819956 |
| 7 | Increased IgM level (HP:0003496) | 4.36126483 |
| 8 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.27808507 |
| 9 | Aplasia of the phalanges of the hand (HP:0009802) | 4.27808507 |
| 10 | Aplasia involving bones of the extremities (HP:0009825) | 4.27808507 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.89934503 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.57328349 |
| 13 | Cerebral inclusion bodies (HP:0100314) | 3.54638994 |
| 14 | Lip pit (HP:0100267) | 3.53100933 |
| 15 | Megalencephaly (HP:0001355) | 3.52842720 |
| 16 | Disinhibition (HP:0000734) | 3.41702963 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.37330374 |
| 18 | Clumsiness (HP:0002312) | 3.34527529 |
| 19 | Abnormality of secondary sexual hair (HP:0009888) | 3.21725834 |
| 20 | Abnormality of the axillary hair (HP:0100134) | 3.21725834 |
| 21 | Plantar hyperkeratosis (HP:0007556) | 2.98438294 |
| 22 | Palmoplantar hyperkeratosis (HP:0000972) | 2.95235492 |
| 23 | Pustule (HP:0200039) | 2.92209798 |
| 24 | Increased IgE level (HP:0003212) | 2.91392920 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 2.90073188 |
| 26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.86622095 |
| 27 | Stomatitis (HP:0010280) | 2.85991120 |
| 28 | Amyloidosis (HP:0011034) | 2.84958661 |
| 29 | Abnormality of T cell number (HP:0011839) | 2.81868884 |
| 30 | Xanthomatosis (HP:0000991) | 2.81550581 |
| 31 | Abnormality of macrophages (HP:0004311) | 2.81459406 |
| 32 | Humeroradial synostosis (HP:0003041) | 2.78188750 |
| 33 | Synostosis involving the elbow (HP:0003938) | 2.78188750 |
| 34 | Enlarged epiphyses (HP:0010580) | 2.75538942 |
| 35 | Hypoplastic left heart (HP:0004383) | 2.74475203 |
| 36 | Palmar hyperkeratosis (HP:0010765) | 2.71829083 |
| 37 | Paraparesis (HP:0002385) | 2.71686891 |
| 38 | Hypergammaglobulinemia (HP:0010702) | 2.70989776 |
| 39 | Parakeratosis (HP:0001036) | 2.68599909 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.67819844 |
| 41 | Supranuclear gaze palsy (HP:0000605) | 2.64167460 |
| 42 | Thick nail (HP:0001805) | 2.60248403 |
| 43 | Alopecia of scalp (HP:0002293) | 2.59340395 |
| 44 | Onycholysis (HP:0001806) | 2.56957217 |
| 45 | Hyperventilation (HP:0002883) | 2.55143390 |
| 46 | Eosinophilia (HP:0001880) | 2.54993008 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.54297986 |
| 48 | Corneal erosion (HP:0200020) | 2.51972677 |
| 49 | Neonatal hypoglycemia (HP:0001998) | 2.49546603 |
| 50 | Hypochromic anemia (HP:0001931) | 2.48509917 |
| 51 | Recurrent abscess formation (HP:0002722) | 2.48204308 |
| 52 | Vasculitis (HP:0002633) | 2.47593843 |
| 53 | Oral leukoplakia (HP:0002745) | 2.47557767 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.47510492 |
| 55 | Patchy hypopigmentation of hair (HP:0011365) | 2.42756501 |
| 56 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.42742849 |
| 57 | Progressive neurologic deterioration (HP:0002344) | 2.42714753 |
| 58 | Myositis (HP:0100614) | 2.42044855 |
| 59 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.41979089 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.38764694 |
| 61 | Split foot (HP:0001839) | 2.38535008 |
| 62 | Spastic paraparesis (HP:0002313) | 2.37065149 |
| 63 | Erythema (HP:0010783) | 2.36055024 |
| 64 | Hemiparesis (HP:0001269) | 2.33890428 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.33502433 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.30993771 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.30993771 |
| 68 | Recurrent bacterial skin infections (HP:0005406) | 2.29757482 |
| 69 | Obstructive lung disease (HP:0006536) | 2.28378544 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28378544 |
| 71 | Abnormal blistering of the skin (HP:0008066) | 2.28227184 |
| 72 | Hypotrichosis (HP:0001006) | 2.28215765 |
| 73 | Granulocytopenia (HP:0001913) | 2.28129677 |
| 74 | Septate vagina (HP:0001153) | 2.26954447 |
| 75 | Dry hair (HP:0011359) | 2.25085872 |
| 76 | Short hallux (HP:0010109) | 2.24938569 |
| 77 | Orchitis (HP:0100796) | 2.24397778 |
| 78 | Tetraparesis (HP:0002273) | 2.23416632 |
| 79 | Hypoplastic heart (HP:0001961) | 2.23316844 |
| 80 | White forelock (HP:0002211) | 2.23022089 |
| 81 | Milia (HP:0001056) | 2.22777013 |
| 82 | Loss of speech (HP:0002371) | 2.22529969 |
| 83 | Mixed hearing impairment (HP:0000410) | 2.21467574 |
| 84 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21191038 |
| 85 | Xerostomia (HP:0000217) | 2.20816645 |
| 86 | Flat occiput (HP:0005469) | 2.17385868 |
| 87 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.16319636 |
| 88 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.15075026 |
| 89 | Ridged nail (HP:0001807) | 2.15044560 |
| 90 | Glomerulonephritis (HP:0000099) | 2.13597575 |
| 91 | Abnormality of nail color (HP:0100643) | 2.13107534 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.11451402 |
| 93 | Nail dystrophy (HP:0008404) | 2.09453390 |
| 94 | Ectropion (HP:0000656) | 2.07653984 |
| 95 | Retrobulbar optic neuritis (HP:0100654) | 2.07538080 |
| 96 | Optic neuritis (HP:0100653) | 2.07538080 |
| 97 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.07239666 |
| 98 | Glucose intolerance (HP:0000833) | 2.07140656 |
| 99 | Erythroderma (HP:0001019) | 2.06734466 |
| 100 | Methylmalonic acidemia (HP:0002912) | 2.05953470 |
| 101 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.03516147 |
| 102 | Abnormality of the prostate (HP:0008775) | 2.02890029 |
| 103 | Meningitis (HP:0001287) | 2.01900692 |
| 104 | Malnutrition (HP:0004395) | 1.97482081 |
| 105 | Dysostosis multiplex (HP:0000943) | 1.95281253 |
| 106 | Partial duplication of thumb phalanx (HP:0009944) | 1.95184144 |
| 107 | Keratoconjunctivitis (HP:0001096) | 1.94457291 |
| 108 | Increased serum ferritin (HP:0003281) | 1.93816797 |
| 109 | Axonal loss (HP:0003447) | 1.93083587 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92146030 |
| 111 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92146030 |
| 112 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92146030 |
| 113 | Cheilitis (HP:0100825) | 1.91750072 |
| 114 | Skin rash (HP:0000988) | 1.91116629 |
| 115 | Prostate neoplasm (HP:0100787) | 1.89485476 |
| 116 | Pulmonary infiltrates (HP:0002113) | 1.88441073 |
| 117 | Neoplasm of head and neck (HP:0012288) | 1.88209484 |
| 118 | Esophageal neoplasm (HP:0100751) | 1.88209484 |
| 119 | Petechiae (HP:0000967) | 1.88165645 |
| 120 | Conjugated hyperbilirubinemia (HP:0002908) | 1.87528809 |
| 121 | Mutism (HP:0002300) | 1.87477793 |
| 122 | Retinal dysplasia (HP:0007973) | 1.87138016 |
| 123 | Methylmalonic aciduria (HP:0012120) | 1.87114380 |
| 124 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.86699315 |
| 125 | Premature loss of primary teeth (HP:0006323) | 1.85849863 |
| 126 | Prolonged partial thromboplastin time (HP:0003645) | 1.83158024 |
| 127 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.82227553 |
| 128 | Recurrent skin infections (HP:0001581) | 1.81988950 |
| 129 | Abnormality of T cells (HP:0002843) | 1.81984122 |
| 130 | Complement deficiency (HP:0004431) | 1.81909278 |
| 131 | Urticaria (HP:0001025) | 1.81657927 |
| 132 | Metabolic alkalosis (HP:0200114) | 1.80533084 |
| 133 | Thickened helices (HP:0000391) | 1.80040713 |
| 134 | Decreased circulating renin level (HP:0003351) | 1.79897386 |
| 135 | Constricted visual fields (HP:0001133) | 1.79862104 |
| 136 | Hepatosplenomegaly (HP:0001433) | 1.79216886 |
| 137 | Abnormality of B cell number (HP:0010975) | 1.79045466 |
| 138 | Chronic otitis media (HP:0000389) | 1.78456275 |
| 139 | Dehydration (HP:0001944) | 1.78390329 |
| 140 | Polyneuropathy (HP:0001271) | 1.78007113 |
| 141 | Sparse eyelashes (HP:0000653) | 1.77259860 |
| 142 | Sensorimotor neuropathy (HP:0007141) | 1.76615273 |
| 143 | Woolly hair (HP:0002224) | 1.76576191 |
| 144 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.76415594 |
| 145 | Abnormality of glycine metabolism (HP:0010895) | 1.76415594 |
| 146 | Gangrene (HP:0100758) | 1.76322608 |
| 147 | Long nose (HP:0003189) | 1.74361992 |
| 148 | Basal ganglia calcification (HP:0002135) | 1.74107100 |
| 149 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.73912590 |
| 150 | Abnormality of the dental pulp (HP:0006479) | 1.73762967 |
| 151 | Hypoalphalipoproteinemia (HP:0003233) | 1.72541146 |
| 152 | Systemic lupus erythematosus (HP:0002725) | 1.72345335 |
| 153 | Abnormality of binocular vision (HP:0011514) | 1.71630768 |
| 154 | Diplopia (HP:0000651) | 1.71630768 |
| 155 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69505476 |
| 156 | Epileptic encephalopathy (HP:0200134) | 1.68612249 |
| 157 | Hemiplegia (HP:0002301) | 1.67353373 |
| 158 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.66529919 |
| 159 | Conical tooth (HP:0000698) | 1.65930532 |
| 160 | Slow saccadic eye movements (HP:0000514) | 1.65889455 |
| 161 | Abnormality of permanent molar morphology (HP:0011071) | 1.65718506 |
| 162 | Abnormality of the dental root (HP:0006486) | 1.65718506 |
| 163 | Taurodontia (HP:0000679) | 1.65718506 |
| 164 | Broad alveolar ridges (HP:0000187) | 1.65557374 |
| 165 | Abnormality of the 2nd finger (HP:0004100) | 1.65446604 |
| 166 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.64744499 |
| 167 | Fat malabsorption (HP:0002630) | 1.63352498 |
| 168 | Hypolipoproteinemia (HP:0010981) | 1.63284968 |
| 169 | Poor suck (HP:0002033) | 1.62006678 |
| 170 | Fragile nails (HP:0001808) | 1.61932046 |
| 171 | Mediastinal lymphadenopathy (HP:0100721) | 1.60691585 |
| 172 | Coronal craniosynostosis (HP:0004440) | 1.58736964 |
| 173 | Abnormality of molar morphology (HP:0011070) | 1.58635024 |
| 174 | Abnormality of molar (HP:0011077) | 1.58635024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 5.44060675 |
| 2 | TNIK | 4.48442754 |
| 3 | MUSK | 3.83105475 |
| 4 | NME2 | 3.55271379 |
| 5 | LMTK2 | 2.96221571 |
| 6 | CASK | 2.81574692 |
| 7 | EPHB1 | 2.75485087 |
| 8 | IRAK3 | 2.48625776 |
| 9 | PBK | 2.42328007 |
| 10 | EPHA4 | 2.32819467 |
| 11 | GRK7 | 2.10475606 |
| 12 | MAP4K2 | 2.09997491 |
| 13 | MST4 | 2.08385371 |
| 14 | PHKG2 | 2.07625393 |
| 15 | PHKG1 | 2.07625393 |
| 16 | MAPKAPK5 | 2.05091984 |
| 17 | MAP3K14 | 1.86923332 |
| 18 | EPHA2 | 1.86086829 |
| 19 | OXSR1 | 1.84381417 |
| 20 | STK39 | 1.82651989 |
| 21 | PRPF4B | 1.79913519 |
| 22 | RIPK4 | 1.73181165 |
| 23 | EIF2AK3 | 1.71753830 |
| 24 | MST1R | 1.66758624 |
| 25 | FGR | 1.59933424 |
| 26 | TAOK3 | 1.57967329 |
| 27 | MET | 1.54307657 |
| 28 | STK10 | 1.52509137 |
| 29 | KIT | 1.48213420 |
| 30 | SIK1 | 1.47114395 |
| 31 | TBK1 | 1.42171392 |
| 32 | CDK3 | 1.39944230 |
| 33 | NEK6 | 1.30752235 |
| 34 | MAP2K6 | 1.29540668 |
| 35 | ABL2 | 1.27172622 |
| 36 | NTRK2 | 1.24288703 |
| 37 | MAP3K6 | 1.22225799 |
| 38 | PIM2 | 1.18322045 |
| 39 | PKN1 | 1.18208137 |
| 40 | MOS | 1.17222768 |
| 41 | MAP3K13 | 1.16303103 |
| 42 | TYK2 | 1.16009171 |
| 43 | BLK | 1.14980811 |
| 44 | TAOK2 | 1.14772840 |
| 45 | MAP2K3 | 1.14639394 |
| 46 | CSF1R | 1.13322938 |
| 47 | CDK19 | 1.12348595 |
| 48 | PIK3CA | 1.12064020 |
| 49 | IKBKE | 1.11682379 |
| 50 | ERBB4 | 1.11567149 |
| 51 | ZAP70 | 1.11009167 |
| 52 | ADRBK2 | 1.09699849 |
| 53 | TESK2 | 1.09170181 |
| 54 | MAPK12 | 1.09099255 |
| 55 | TRPM7 | 1.07133632 |
| 56 | MAP2K7 | 1.03742720 |
| 57 | BCKDK | 0.97663737 |
| 58 | CAMKK2 | 0.96964701 |
| 59 | FLT3 | 0.92991296 |
| 60 | ERN1 | 0.91903725 |
| 61 | TXK | 0.90960960 |
| 62 | MAP3K12 | 0.90641756 |
| 63 | MAPK7 | 0.90519652 |
| 64 | SGK223 | 0.89513039 |
| 65 | SGK494 | 0.89513039 |
| 66 | PRKCQ | 0.87952150 |
| 67 | MAP3K3 | 0.84979531 |
| 68 | YES1 | 0.84071168 |
| 69 | EIF2AK2 | 0.83167466 |
| 70 | CAMK2D | 0.82973717 |
| 71 | FES | 0.82156870 |
| 72 | JAK3 | 0.81561955 |
| 73 | CAMK2G | 0.81437943 |
| 74 | MAPK13 | 0.81031920 |
| 75 | PINK1 | 0.80822004 |
| 76 | BMPR1B | 0.80574760 |
| 77 | MAP3K7 | 0.79115224 |
| 78 | PRKCE | 0.78904829 |
| 79 | CAMK1D | 0.78195607 |
| 80 | IRAK4 | 0.78162125 |
| 81 | GRK6 | 0.71840605 |
| 82 | LYN | 0.70696573 |
| 83 | TGFBR2 | 0.68866433 |
| 84 | PDK2 | 0.68772245 |
| 85 | BMPR2 | 0.68202046 |
| 86 | EPHB2 | 0.67994944 |
| 87 | CAMK2B | 0.67393268 |
| 88 | PRKG2 | 0.66864094 |
| 89 | MAP3K2 | 0.66736051 |
| 90 | TGFBR1 | 0.65287343 |
| 91 | IKBKB | 0.64176795 |
| 92 | PTK2 | 0.63250299 |
| 93 | ARAF | 0.63035080 |
| 94 | STK24 | 0.61799260 |
| 95 | SCYL2 | 0.61009382 |
| 96 | MAP3K11 | 0.59838950 |
| 97 | TEC | 0.58413715 |
| 98 | MKNK2 | 0.57608817 |
| 99 | CAMK2A | 0.56518984 |
| 100 | BTK | 0.54620213 |
| 101 | STK16 | 0.54472306 |
| 102 | MARK3 | 0.54393013 |
| 103 | ACVR1B | 0.54289982 |
| 104 | IRAK1 | 0.53284542 |
| 105 | MAP4K1 | 0.53248107 |
| 106 | BMX | 0.52883695 |
| 107 | PIK3CG | 0.51345460 |
| 108 | EIF2AK1 | 0.51027249 |
| 109 | PRKAA2 | 0.49458598 |
| 110 | IGF1R | 0.49292098 |
| 111 | MKNK1 | 0.49176978 |
| 112 | FYN | 0.48789971 |
| 113 | PRKD3 | 0.48504264 |
| 114 | MAP3K5 | 0.48286262 |
| 115 | MATK | 0.48260833 |
| 116 | PDPK1 | 0.48130538 |
| 117 | ROCK2 | 0.47069938 |
| 118 | HCK | 0.46016060 |
| 119 | MAPK4 | 0.45062286 |
| 120 | TESK1 | 0.44991852 |
| 121 | ADRBK1 | 0.44265182 |
| 122 | JAK2 | 0.43856089 |
| 123 | ABL1 | 0.43391662 |
| 124 | SYK | 0.42576590 |
| 125 | LCK | 0.42560636 |
| 126 | PRKCA | 0.42077892 |
| 127 | ERBB3 | 0.41299341 |
| 128 | RPS6KB2 | 0.40256352 |
| 129 | PDGFRB | 0.39993591 |
| 130 | FGFR2 | 0.39983569 |
| 131 | PRKCD | 0.39764295 |
| 132 | CSK | 0.38199028 |
| 133 | ITK | 0.38004430 |
| 134 | CSNK1G2 | 0.37932353 |
| 135 | GRK1 | 0.37705617 |
| 136 | MARK2 | 0.35701577 |
| 137 | CDK5 | 0.35676889 |
| 138 | MAPK11 | 0.35632464 |
| 139 | JAK1 | 0.35479280 |
| 140 | PAK3 | 0.35384362 |
| 141 | CHUK | 0.35036506 |
| 142 | PDK1 | 0.34389328 |
| 143 | PRKD1 | 0.34265776 |
| 144 | NTRK1 | 0.34010136 |
| 145 | INSR | 0.27893759 |
| 146 | CDK6 | 0.26224229 |
| 147 | EGFR | 0.24229827 |
| 148 | ILK | 0.24111039 |
| 149 | MAPKAPK3 | 0.22711112 |
| 150 | MYLK | 0.20498091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.58276634 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.97209615 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.80698125 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.42856455 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.42815569 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.10528076 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.06613226 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73809428 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.71349515 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.26952939 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04550925 |
| 12 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.04188096 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99178708 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86979875 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83442757 |
| 16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.82903792 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78359548 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.69134799 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.67848658 |
| 20 | Mineral absorption_Homo sapiens_hsa04978 | 1.67785598 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.65132494 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.59960016 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.58526649 |
| 24 | * Influenza A_Homo sapiens_hsa05164 | 1.58257440 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.56424089 |
| 26 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55563515 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.55062196 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54274705 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54227607 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.47209189 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37834992 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36960813 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36515032 |
| 34 | * Legionellosis_Homo sapiens_hsa05134 | 1.36255946 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.33455113 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33201044 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31319768 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29219024 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27117148 |
| 40 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.25968064 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24932032 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23912230 |
| 43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21334002 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21198686 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.18746266 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17200629 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.16374403 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16141035 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12468034 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.11452262 |
| 51 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.09881731 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09569768 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.04825849 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04488261 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02977729 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.02690808 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01934305 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01593667 |
| 59 | * Salmonella infection_Homo sapiens_hsa05132 | 1.01360202 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98369379 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.98041574 |
| 62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.97853000 |
| 63 | * Malaria_Homo sapiens_hsa05144 | 0.95422928 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91244627 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.90823474 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.85589455 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84112247 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81537250 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81076631 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77839634 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75252243 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74709077 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74663675 |
| 74 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74049715 |
| 75 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.74032429 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73372416 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73214670 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72121648 |
| 79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70042829 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.69950860 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69816696 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67756660 |
| 83 | Shigellosis_Homo sapiens_hsa05131 | 0.66960747 |
| 84 | GABAergic synapse_Homo sapiens_hsa04727 | 0.66895526 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65069336 |
| 86 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64124529 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62737772 |
| 88 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61950496 |
| 89 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61792758 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61372059 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61301162 |
| 92 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61244269 |
| 93 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.60176228 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60056842 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60019341 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59743980 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.59294214 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.58565898 |
| 99 | Salivary secretion_Homo sapiens_hsa04970 | 0.58155711 |
| 100 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.58056862 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57659959 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56969187 |
| 103 | Apoptosis_Homo sapiens_hsa04210 | 0.56047211 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55938229 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53983632 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50324869 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49875568 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49651751 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46642602 |
| 110 | * Tuberculosis_Homo sapiens_hsa05152 | 0.44718283 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44090829 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44034285 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43818474 |
| 114 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42672651 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42663694 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41697202 |
| 117 | Allograft rejection_Homo sapiens_hsa05330 | 0.41666260 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41602618 |
| 119 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40629820 |
| 120 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.40612752 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40520821 |
| 122 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40483508 |
| 123 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.40229164 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.40123009 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39567798 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39098758 |
| 127 | Hepatitis C_Homo sapiens_hsa05160 | 0.38228557 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37116320 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35942892 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35170237 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.34706787 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.34222918 |
| 133 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.33836633 |
| 134 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33832293 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.32839518 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31970942 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30679684 |
| 138 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.30213973 |
| 139 | Proteasome_Homo sapiens_hsa03050 | 0.28790508 |
| 140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26937629 |
| 141 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.26731505 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.26408721 |
| 143 | Circadian entrainment_Homo sapiens_hsa04713 | 0.25717138 |
| 144 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23262159 |
| 145 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.22178061 |
| 146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18535582 |

